Clinical snapshot — for veterinary teams
- Active ingredient / class: robenacoxib — coxib-class, COX-2-selective NSAID (spares much of the COX-1 activity that protects stomach, kidneys, platelets; concentrates at inflamed tissue)
- Approved use: short-term post-operative pain and inflammation in cats and dogs (US: typically up to 3 days; cats ≥4 months and >5.5 lb)
- Off-label: osteoarthritis/chronic pain beyond 3 days under veterinary supervision — a meaningful option for feline OA, where choices are limited
- Dosing: once daily at the same time (cats 1 mg/kg, dogs 2 mg/kg); flavored tablets are not scoreable — give whole; with or without food (food helps if vomiting)
- Monitoring windows that matter: GI tolerance over the short course; for extended use, baseline + periodic CBC/renal/hepatic panels; response check (discontinue if no response by ~10 days in OA)
- Counsel clients on: common minor effects — soft stools, vomiting (reduced with food); uncommon but serious GI/renal/hepatic toxicity as an NSAID class; never double a dose
- Caution: dehydration, pre-existing renal/GI/hepatic disease; don’t combine with other NSAIDs or steroids
Plain answer for owners who landed here: Onsior (robenacoxib) is an anti-inflammatory pain reliever for cats and dogs, most often used for a few days after surgery, and sometimes longer for arthritis under a vet’s care. It’s designed to be gentler on the stomach and kidneys than older anti-inflammatories, but those risks still exist. Common effects are mild — soft stool or occasional vomiting, eased by giving with food. Give it once daily as directed, never give extra, and if it’s being used longer-term, keep up with the bloodwork your vet recommends.
What it’s used for — and why follow-up matters
Onsior’s COX-2 selectivity makes it a favored short-course post-operative NSAID and, increasingly, an off-label tool for chronic pain — particularly feline osteoarthritis, where safe long-term options are scarce (alongside the biologic Solensia). That dual use shapes the follow-up. For the 3-day post-op course, the job is confirming GI tolerance and that use stops on schedule. For extended OA use, it becomes an NSAID-monitoring relationship: red-flag screening, bloodwork rechecks, and an honest read on whether it’s actually helping.
The adverse-event and monitoring profile
Per veterinary references and labeling, the only common effects are soft stools and occasional vomiting, which resolve on discontinuation and are reduced by giving with food. Serious effects are uncommon but, as with any NSAID, include GI, renal, and hepatic toxicity — risk that rises with dehydration, poor patient selection, and prolonged use. Tablets are flavored and must be given whole (not divided), once daily at a consistent time. For off-label long-term use, pre-treatment and ongoing monitoring (CBC, renal/hepatic panels, sometimes blood pressure) is standard — commonly at start, then around 2/4/8 weeks, then every 3–6 months — and OA treatment should be reconsidered if there’s no response by about 10 days. (Sources: Onsior (robenacoxib) via PetMD; Robenacoxib — Veterinary Partner/VIN; EMA product information.)
The follow-up window that matters
Two profiles. For post-op (3 days): the short window is GI tolerance and making sure the course ends as directed. For extended OA use: the recurring windows are the early response check (~10 days), then periodic bloodwork and red-flag screening over months — exactly where owner-dependent monitoring tends to lapse.
What to ask clients at follow-up
A check that fits either use:
- Any vomiting or soft/loose stool — and is it being given with food if so?
- (Post-op) Is your pet more comfortable, and did the short course finish as directed?
- (Long-term) Any black/tarry stool, appetite loss, increased thirst/urination, lethargy, or jaundice? Is the recheck bloodwork booked?
- Are you giving whole tablets once daily, with nothing else anti-inflammatory added?
The post-op questions confirm a clean recovery; the long-term questions are the NSAID-safety record that extended feline OA use depends on.
Where compliance breaks down
For post-op courses, mild GI upset can make an owner stop early or, conversely, continue leftover tablets beyond the intended window. For long-term OA use, the familiar NSAID failure: deferred monitoring bloodwork and unreported early red flags. Both are follow-up gaps, not prescribing errors.
Standardizing this follow-up without adding staff time
This is what Nidana Loop automates. After an Onsior prescription, Loop calls or texts to screen GI tolerance and confirm correct dosing — and, for extended OA use, carries the red-flag screen, the response check, and the recheck-bloodwork reminders — returning it as a structured note and flagging concerns to a vet. Whether it’s a 3-day post-op course or months of feline OA management, the safety follow-up becomes consistent and documented, with no staff calls.
See Loop handle medication follow-up
Loop runs your post-op tolerance check and long-term NSAID red-flag/recheck reminders automatically — returning structured outcomes to the clinic. Book a 20-minute demo → · See how Loop works →
For pet owners
What is Onsior used for in cats? Most often a few days of pain control after surgery; sometimes longer for arthritis under your vet’s supervision.
Is it safer than other NSAIDs? It’s COX-2 selective, designed to be gentler on the stomach and kidneys, but GI, kidney, and liver risks still exist — especially with longer use.
How do I give it? One whole tablet once daily at the same time (don’t split it); food can help if your pet gets an upset stomach.
What should make me call the vet? Black/tarry stool, appetite loss, increased thirst or urination, lethargy, or yellow gums/eyes.
This article is general information, not veterinary advice. Owners should consult their veterinarian and follow the product’s label.
Sources: Onsior (robenacoxib) via PetMD; Robenacoxib — Veterinary Partner/VIN; EMA Onsior product information.